153 related articles for article (PubMed ID: 36625478)
1. Sample size calculation for clinical trials analyzed with the meta-analytic-predictive approach.
Qi H; Rizopoulos D; van Rosmalen J
Res Synth Methods; 2023 May; 14(3):396-413. PubMed ID: 36625478
[TBL] [Abstract][Full Text] [Related]
2. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
Hupf B; Bunn V; Lin J; Dong C
Stat Med; 2021 Jun; 40(14):3385-3399. PubMed ID: 33851441
[TBL] [Abstract][Full Text] [Related]
3. A novel power prior approach for borrowing historical control data in clinical trials.
Shi Y; Li W; Liu GF
Stat Methods Med Res; 2023 Mar; 32(3):493-508. PubMed ID: 36601652
[TBL] [Abstract][Full Text] [Related]
4. Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical data.
Liu M; Bunn V; Hupf B; Lin J; Lin J
Stat Med; 2021 Sep; 40(22):4794-4808. PubMed ID: 34126656
[TBL] [Abstract][Full Text] [Related]
5. Incorporating historical control information in ANCOVA models using the meta-analytic-predictive approach.
Qi H; Rizopoulos D; van Rosmalen J
Res Synth Methods; 2022 Nov; 13(6):681-696. PubMed ID: 35439840
[TBL] [Abstract][Full Text] [Related]
6. Robust meta-analytic-predictive priors in clinical trials with historical control information.
Schmidli H; Gsteiger S; Roychoudhury S; O'Hagan A; Spiegelhalter D; Neuenschwander B
Biometrics; 2014 Dec; 70(4):1023-32. PubMed ID: 25355546
[TBL] [Abstract][Full Text] [Related]
7. Bayesian borrowing from historical control data in a vaccine efficacy trial.
Peng L; Jin J; Chambonneau L; Zhao X; Zhang J
Pharm Stat; 2023; 22(5):815-835. PubMed ID: 37226586
[TBL] [Abstract][Full Text] [Related]
8. Elastic meta-analytic-predictive prior for dynamically borrowing information from historical data with application to biosimilar clinical trials.
Zhang W; Pan Z; Yuan Y
Contemp Clin Trials; 2021 Nov; 110():106559. PubMed ID: 34506959
[TBL] [Abstract][Full Text] [Related]
9. BEATS: Bayesian hybrid design with flexible sample size adaptation for time-to-event endpoints.
Bi D; Liu M; Lin J; Liu R
Stat Med; 2023 Dec; 42(30):5708-5722. PubMed ID: 37858287
[TBL] [Abstract][Full Text] [Related]
10. Using horseshoe prior for incorporating multiple historical control data in randomized controlled trials.
Ohigashi T; Maruo K; Sozu T; Gosho M
Stat Methods Med Res; 2022 Jul; 31(7):1392-1404. PubMed ID: 35379046
[TBL] [Abstract][Full Text] [Related]
11. A Comparison Between a Meta-analytic Approach and Power Prior Approach to Using Historical Control Information in Clinical Trials With Binary Endpoints.
Isogawa N; Takeda K; Maruo K; Daimon T
Ther Innov Regul Sci; 2020 May; 54(3):559-570. PubMed ID: 33301135
[TBL] [Abstract][Full Text] [Related]
12. Modified power prior with multiple historical trials for binary endpoints.
Banbeta A; van Rosmalen J; Dejardin D; Lesaffre E
Stat Med; 2019 Mar; 38(7):1147-1169. PubMed ID: 30360016
[TBL] [Abstract][Full Text] [Related]
13. Deep historical borrowing framework to prospectively and simultaneously synthesize control information in confirmatory clinical trials with multiple endpoints.
Zhan T; Zhou Y; Geng Z; Gu Y; Kang J; Wang L; Huang X; Slate EH
J Biopharm Stat; 2022 Jan; 32(1):90-106. PubMed ID: 34632951
[TBL] [Abstract][Full Text] [Related]
14. Bayesian noninferiority test for 2 binomial probabilities as the extension of Fisher exact test.
Doi M; Takahashi F; Kawasaki Y
Stat Med; 2017 Dec; 36(30):4789-4803. PubMed ID: 28960376
[TBL] [Abstract][Full Text] [Related]
15. Bayesian clinical trial design using historical data that inform the treatment effect.
Psioda MA; Ibrahim JG
Biostatistics; 2019 Jul; 20(3):400-415. PubMed ID: 29547966
[TBL] [Abstract][Full Text] [Related]
16. A Bayesian group sequential design for randomized biosimilar clinical trials with adaptive information borrowing from historical data.
Zhang W; Pan Z; Yuan Y
J Biopharm Stat; 2022 May; 32(3):359-372. PubMed ID: 35679137
[TBL] [Abstract][Full Text] [Related]
17. Elastic priors to dynamically borrow information from historical data in clinical trials.
Jiang L; Nie L; Yuan Y
Biometrics; 2023 Mar; 79(1):49-60. PubMed ID: 34437714
[TBL] [Abstract][Full Text] [Related]
18. The power prior with multiple historical controls for the linear regression model.
Banbeta A; Lesaffre E; van Rosmalen J
Pharm Stat; 2022 Mar; 21(2):418-438. PubMed ID: 34851549
[TBL] [Abstract][Full Text] [Related]
19. Bayesian adaptive randomization design incorporating propensity score-matched historical controls.
Sawamoto R; Oba K; Matsuyama Y
Pharm Stat; 2022 Sep; 21(5):1074-1089. PubMed ID: 35278032
[TBL] [Abstract][Full Text] [Related]
20. Empirical Bayes models of Poisson clinical trials and sample size determination.
Zaslavsky BG
Pharm Stat; 2010; 9(2):133-41. PubMed ID: 19513984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
